Tag: cardiovascular disease

SHOULD COST-EFFECTIVENESS BE INCLUDED IN CLINICAL TREATMENT GUIDELINES?

At ISPOR’s Annual International Meeting, speakers addressed cost-effectiveness issues at both societal and patient levels Princeton, NJ, USA, May 19, 2015 – Oncology and cardiology professional organizations have embraced consideration of cost-effectiveness and the value of treatments in developing their

Posted in Announcements, ISPOR News & Press Tagged with: , , , , ,

Models To Predict Cardiovascular Disease Risk In Vietnam

Thai Nguyen, Vietnam & Groningen, the Netherlands – The burden of cardiovascular diseases (CVD) is increasing worldwide, including in Vietnam. To make the best use of limited resources, planning of health care interventions is important. Predictive modeling of the risk of CVD

Posted in Value in Health Regional Issues Tagged with: , ,